Acute Intermittent Porphyria (HMBS) - Gene Analysis in Hyderabad

Also known as: Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood**

50+ booked in last 3 days

No special precautions

Sample Type

Blood

Recommended for

Male, Female

Blood test at Home

NABL & CAP Accredited Labs

Accurate & Quality Test Reports

Trusted by Leading Doctors & Hospitals

Overview

Your body produces a chemical called HMBS, crucial for normal cell function. Mutations in the HMBS gene can lead to Acute Intermittent Porphyria (AIP). This condition disrupts haemoglobin production, causing a build-up of porphyrins. Porphyrins are essential for haemoglobin synthesis and play a role in oxygen transport.

Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood** Price in Hyderabad

Metropolis Healthcare is a leading diagnostics centre and pathology lab in India equipped with the latest state-of-the-art technologies that provides the Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood** with a clear pricing structure

The price of Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood** in Hyderabad is ₹ 20,000

We are committed to deliver accurate and quality results from the best labs in India with complete transparency regarding test cost and turnaround time. No matter where you are, we strive to offer patients high-quality service that is affordable and accessible.

Frequently Asked Questions

Why take Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood**?

Is this test for you?

More Info on Acute Intermittent Porphyria (HMBS ) Gene Panel by NGS, EDTA Blood**

Ratings & Reviews (0)

No reviews available

Why Metropolis?

Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.

We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.